Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

Share Price is delayed by 15 minutes
Get Live Data
37.00    -1.50 (-3.90%)
Bid:
36.94
Ask:
37.00
Spread: 0.06 (0.162%)
Market Cap: £374.70m
AML Live PriceLast checked at - London Stock Exchange

Intraday Aston Martin Lagonda Share Chart

Increased investment by Yew Tree Consortium

29 Sep 2023 07:00

RNS Number : 0888O
Aston Martin Lagonda Glob.Hldgs PLC
29 September 2023
 

29 September 2023

Aston Martin Lagonda Global Holdings plc

("the "Company")

Increased investment by Yew Tree Consortium

 

The Company announces that it has been informed that on 28 September 2023 certain members of the Yew Tree Consortium have agreed to purchase an additional 26 million ordinary shares in the Company. As a result of this purchase, the Yew Tree Consortium will hold a total of 26.23% of the Company's issued ordinary share capital.

Regulatory announcements with respect to this purchase by the Yew Tree Consortium will be made in due course.

Lawrence Stroll, on behalf of the Yew Tree Consortium, said: "The Yew Tree Consortium is delighted to increase its ownership in the Company by 3.27%. This additional investment demonstrates the Yew Tree Consortium's continuing confidence and belief in the future of Aston Martin. The Company has delivered a major turnaround since the Yew Tree Consortium's initial investment three years ago. We have rebuilt this iconic company, transforming it into an ultra-luxury brand, with a portfolio of highly desirable, performance-driven cars. This increased investment demonstrates our continuing, long-term commitment to the Company, our conviction for the future and the shareholder value the Company will deliver." 

 

This Announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation EU 596/2016 as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018. The person responsible for releasing this announcement on behalf of Aston Martin Lagonda Global Holdings plc is Liz Miles, Company Secretary.

 

Enquiries

Investor Relations

Robert Berg

+44 (0)7833 080458

Robert.berg@astonmartin.com

 

Media

Kevin Watters

+44 (0)7764 386683kevin.watters@astonmartin.com

 

Paul Garbett

 

+44 (0)7501 380799 paul.garbett@astonmartin.com

 

Teneo

Harry Cameron

 

+44 (0)20 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSEIEDAEDSEEU
Date   Source Headline
26th Jun 20269:00 amRNSYew Tree Consortium Facility closing conditions
9th Jun 202611:32 amRNSDirector/PDMR Shareholding
4th Jun 20267:00 amRNSIssue of equity to satisfy share awards
15th May 20267:00 amRNSIssue of equity to satisfy employee share awards
6th May 202612:51 pmRNSVoting results of AGM 2026
29th Apr 20267:00 amRNSQ1 results for three months ended 31 March 2026
25th Mar 20269:53 amRNSAnnual Financial Report
9th Mar 202612:12 pmRNSResult of Meeting
25th Feb 20267:00 amRNSPreliminary Results FY2025
20th Feb 20267:00 amRNSNotice of GM and FY 2025 Trading Update
29th Oct 20257:00 amRNSQ3 results for the quarter ended 30 September 2025
6th Oct 20257:00 amRNSQ3 2025 Trading Update and revised outlook
10th Sep 202511:33 amRNSDirector/PDMR Shareholding
5th Sep 20257:00 amRNSIssue of equity to satisfy employee share awards
30th Jul 20257:00 amRNSInterim results
28th Jul 20254:33 pmRNSDirectorate Change
27th May 202510:13 amRNSDirector/PDMR Shareholding
27th May 202510:12 amRNSDirector/PDMR Shareholding
15th May 202510:38 amRNSHolding(s) in Company
13th May 20255:26 pmRNSHolding(s) in Company
13th May 202510:33 amRNSDirector/PDMR Shareholding
13th May 202510:31 amRNSDirector/PDMR Shareholding
13th May 202510:26 amRNSDirector/PDMR Shareholding
12th May 20255:53 pmRNSHolding(s) in Company
12th May 20251:13 pmRNSHolding(s) in Company
12th May 202512:52 pmRNSHolding(s) in Company
7th May 20252:45 pmRNSDirector/PDMR Shareholding
7th May 20251:15 pmRNSResult of General Meeting and issue of equity
7th May 20251:07 pmRNSVoting Result of AGM
30th Apr 20257:00 amRNS1st Quarter Results
17th Apr 20258:57 amRNSNotice of General Meeting
16th Apr 20253:20 pmRNSDirector Declaration
31st Mar 20255:11 pmRNSStatement regarding media comments
31st Mar 20257:00 amRNSProposed investment by Yew Tree Consortium
26th Mar 20259:24 amRNSAnnual Financial Report
26th Feb 20257:00 amRNSPreliminary results year ended 31 December 2024
25th Feb 202510:00 amRNSIndependent Non-executive Director appointment
7th Feb 20255:29 pmRNSHolding(s) in Company
13th Dec 20249:00 amRNSDirectorate Change
4th Dec 20244:00 pmRNSHolding(s) in Company
29th Nov 20244:15 pmRNSHolding(s) in Company
29th Nov 20241:01 pmRNSHolding(s) in Company
29th Nov 202412:46 pmRNSDirector/PDMR Shareholding Replacement
29th Nov 202412:18 pmRNSDirector/PDMR Shareholding
29th Nov 202412:17 pmRNSDirector/PDMR Shareholding
29th Nov 202412:11 pmRNSDirector/PDMR Shareholding
27th Nov 20247:00 amRNSResult of Equity Issue
26th Nov 20245:06 pmRNSIssue of Equity
26th Nov 20244:58 pmRNSIssue of Equity
6th Nov 202410:37 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.